LabGenomics Co. Ltd Capital Reinvestment Ratio

Latest as of December 2023: 0.18x

LabGenomics Co. Ltd capital reinvestment ratio. LabGenomics Co. Ltd (084650) has a Capital Reinvestment Ratio of 0.18x as of December 2023, meaning it reinvests 0% of its operating cash flow (₩4.96 Billion) in capital expenditures (₩895.50 Million). Check LabGenomics Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.18x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.96 Billion
KRW

Capital Expenditures

₩895.50 Million
KRW

Data as of

Dec 2023
Most recent filing

Capital Reinvestment Ratio of LabGenomics Co. Ltd (2014–2023)

Capital reinvestment ratio of LabGenomics Co. Ltd from 2014 to 2023. This chart tracks LabGenomics Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore 084650 net asset momentum to track the company's year-over-year net asset growth rate.

LabGenomics Co. Ltd Capital Reinvestment Ratio by Year (2014–2023)

LabGenomics Co. Ltd capital reinvestment ratio by year from 2014 to 2023. For the full cash flow conversion analysis, see LabGenomics Co. Ltd cash flow conversion.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2023 2.15x ₩2.42 Billion ₩5.20 Billion ▲ +291.1%
2022 0.55x ₩69.87 Billion ₩38.33 Billion ▲ +161.4%
2021 0.21x ₩65.36 Billion ₩13.72 Billion ▲ +1291.8%
2020 0.02x ₩46.37 Billion ₩699.21 Million ▼ -91.4%
2019 0.18x ₩3.19 Billion ₩560.94 Million ▼ -94.7%
2018 3.33x ₩608.03 Million ₩2.03 Billion ▲ +108.0%
2016 1.60x ₩2.54 Billion ₩4.08 Billion ▼ -17.6%
2015 1.95x ₩2.38 Billion ₩4.63 Billion ▲ +409.3%
2014 0.38x ₩3.15 Billion ₩1.20 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow